EP 0939634 A4 20010221 - IL-8 RECEPTOR ANTAGONISTS
Title (en)
IL-8 RECEPTOR ANTAGONISTS
Title (de)
IL-8 REZEPTOR ANTAGONISTEN
Title (fr)
ANTAGONISTES DU RECEPTEUR IL-8
Publication
Application
Priority
- US 9714582 W 19970815
- US 2397296 P 19960815
Abstract (en)
[origin: WO9806398A1] This invention relates to novel compounds of formula (I), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, interleukin-8(IL-8).
IPC 1-7
A61K 31/44; A61K 31/495; A61K 31/505; A61K 31/535; C07D 211/56
IPC 8 full level
A61K 31/44 (2006.01); A61K 31/505 (2006.01); A61P 43/00 (2006.01); C07D 213/72 (2006.01); C07D 213/75 (2006.01); C07D 239/42 (2006.01); C07D 239/46 (2006.01)
CPC (source: EP)
A61P 43/00 (2017.12); C07D 213/75 (2013.01); C07D 239/47 (2013.01)
Citation (search report)
- [Y] WO 9507934 A2 19950323 - CHIRON CORP [US]
- [Y] EP 0652228 A1 19950510 - AMERICAN CYANAMID CO [US]
- [Y] WO 9422807 A1 19941013 - NEUROSEARCH AS [DK], et al
- [Y] WO 9404499 A1 19940303 - UPJOHN CO [US], et al
- [Y] WO 9404500 A1 19940303 - UPJOHN CO [US], et al
- [Y] EP 0392802 A2 19901017 - BEECHAM GROUP PLC [GB]
- [PX] WO 9625157 A1 19960822 - SMITHKLINE BEECHAM CORP [US], et al
- See references of WO 9806398A1
Designated contracting state (EPC)
BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
WO 9806398 A1 19980219; EP 0939634 A1 19990908; EP 0939634 A4 20010221; JP 2000516620 A 20001212
DOCDB simple family (application)
US 9714582 W 19970815; EP 97938426 A 19970815; JP 51010798 A 19970815